1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. BEAUTY HEALTH COMPANY (THE) - ORDINARY SHARES - CLASS A
Beauty Health Company (The) - Ordinary Shares - Class A
XNAS: SKIN
Weak Stock
Download real time
0.55-0.02(-3.51%)
New 52W Low today
509.0K
XNAS Volume

XNAS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Split
Beauty Health Company (The) - Ordinary Shares - Class A has split the face value of its shares from $1 to $20 on 14 Oct 2026.See details

Beauty Health Co (Class A) quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Beauty Health Co (Class A) share price target, revenues, EPS, net income and more

Beauty Health Co (Class A) quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEGATIVE

    Quarterly Revenue Beauty Health Co (Class A) Jun-2026 Quarterly Revenue is $72 Million which is growth of -7.8% YoY.

  • NEGATIVE

    Quarterly Net Profit Beauty Health Co (Class A) Jun-2026 Quarterly Net Profit is $-3 Million which is growth of -113.5% YoY.

Beauty Health Company (The) - Ordinary Shares - Class A, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
72.164.982.470.778.269.683.578.890.681.496.897.4117.5
Cost Of Rev.
22.820.529.32529.12131.238.249.73351.111049.6
Gross Profit
49.344.45345.649.148.652.440.740.948.445.7-12.667.9
⌄
45.846.252.951.951.860.659.562.263.165.464.169.681
Operating Profit
3.6-1.80.2-6.2-2.7-12-7.2-21.5-22.1-17-18.4-82.1-13.2
⌄
-5-4.9-4.9-5.1-10.5-0.22.41.72.333.32.3
Profit Before Tax
-1.5-6.8-4.8-10.618.7-9.2-11.7-16.3-0.2-1.3-8.8-70.31.2
Tax
1.2-0.23.30.4-10.9-1.42-0.4-0.70.63.5-2.2
⌄
-2.7-6.6-8.1-1119.7-10.1-10.3-18.30.2-0.7-9.4-73.83.4
Diluted NI Avail to Com Stockholders Ann.
-2.7-7.1-7.6-114.2-10.1-7.8-18.3-14.5-13.8-9.4-73.83.4
Basic EPS
-0-0.1-0.1-0.10.2-0.1-0.1-0.2-0-0.1-0.60
Diluted EPS After ExtraOrdinary
-0-0-0.1-0.10-0.1-0.1-0.2-0.1-0.1-0.1-0.6-0
Number Of Shares End
129.6127.8127.5126.9126.1125.1124.4124.1123.7123.1128.7132.9132.7
Net Income Continuing Discontinued Operations
-2.7-6.6-8.1-1119.7-10.1-10.3-18.30.2-0.7-9.4-73.83.4
Normalized Income
-0.1-4.2-2.6-8.325.8-7.4-0.5-9.813.110.1-4.8-51.21.8
Interest Income
1.31.51.51.33.232.24.94.25.46.46.85.7
Interest
6.36.46.46.34.12.52.52.52.533.43.43.4
Net Interest Income
-5-4.9-4.9-5.1-10.5-0.22.41.72.333.32.3
EBIT
3.5-20.1-5.619.7-9.7-11.5-18.8-1.9-3.7-11.8-73.6-1.1
EBITDA
8.83.45.42.825.1-3.6-4.9-9.275-1.9-65.79.3
Reconciled Cost Of Rev.
22.820.529.32529.12131.238.249.73351.111049.6
Reconciled Depr.
5.35.35.48.45.46.26.69.68.98.710810.5
Profit From Continuing Operations
-2.7-6.6-8.1-1119.7-10.1-10.3-18.30.2-0.7-9.4-73.85.4
Normalized EBITDA
10.26.17.24.124-2.81.7-78.313.1-2.1-62.53.1
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Beauty Health Co (Class A) competitor comparison and performance snapshot within industry

Beauty Health Co (Class A) annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Annual Revenue Beauty Health Co (Class A) Dec-2025 Annual Revenue is $301 Million which is growth of -10.0% YoY.

  • POSITIVE

    Annual Net Profit Beauty Health Co (Class A) Dec-2025 Annual Net Profit is $-10 Million which is growth of 67.3% YoY.

Beauty Health Company (The) - Ordinary Shares - Class A, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18
⌄
-6.3%
20.4%
 300.8334.3398365.9260.1119.1166.6112.3
Cost Of Rev. Ann.
-3.3%
15%
97.6104.4152242.9115.578.351.960.139.3
Gross Profit Ann.
-7.8%
23.9%
192.4196.4182.3155.1250.3181.867.2106.573
Operating Exp. Ann.
-7.5%
20.8%
196.8217.2250.1286274.6218.584.493.162.9
Operating Profit Ann.
-
-
-4.3-20.8-67.8-130.9-24.3-36.6-17.213.510.1
⌄
-
-
-19.8-10.46.29.5-4.2-11.8-21.3-17.1-10.1
Other Exp. Ann.
-30%
-
 25.23219.573.5-328.9-00.7
PBT Ann.
-
-
-23.7-5.9-29.6-101.945-377.4-38.5-2.90
Tax Ann.
72.6%
-
4.73.6-0.5-1.80.7-2.2-9.3-1.30.3
⌄
-
-
-28.4-9.5-29.1-100.144.4-375.1-29.9-1.6-90.9
Diluted NI Avail to Com Stockholders Ann.
-
-
-28.4-22.1-51.8-100.1-34-375.1-29.9-1.6-90.9
EPS Ann.
-
-
 -0.1-0.2-0.80.3-3.7-0.2-0-0.7
Diluted EPS Ann.
-
-
 -0.2-0.4-0.8-0.2-3.7-0.2-0-0.7
Number Of Shares End
-2.6%
0.3%
 127.5124.4128.7138.1146.8125.4--
Total Exp. Ann.
-6.2%
18.7%
 321.6402.1528.9390.2296.7136.3153.2102.3
Net Income Continuing Discontinued Operations Ann.
-
-
-28.4-9.5-29.1-100.144.4-375.1-29.2-1.6-0.3
Normalized Income Ann.
-6.2%
-
-15.27.521.8-52.59.14.5-28.8-1.6-0.3
Interest Income Ann.
-0.7%
-
5.5916.623.29.2----
Interest Ann.
12.9%
-2%
25.319.310.413.713.411.821.317.110.1
EBITDA Ann.
-25.5%
-
20.429.8-2.1-76.772.1-344.3-2.728.121.6
Reconciled Cost Of Rev. Ann.
-3.3%
15%
97.6104.4152242.9115.578.351.960.139.3
Reconciled Depr. Ann.
3.5%
11.9%
24.425.433.734.722.921.314.513.911.5
Profit From Continuing Operations Ann.
-
-
-28.4-9.5-29.1-100.144.4-375.1-29.2-1.6-0.3
Normalized EBITDA Ann.
74.5%
-
27.432.416.1-67.96.1-66.9-2.727.921.6
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
-10%
2Y CAGR
-13.1%
3Y CAGR
-6.3%
5Y CAGR
20.4%
7Y CAGR
15.1%
Total Revenue Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
-13.2%
2Y CAGR
-12.9%
3Y CAGR
-7.5%
5Y CAGR
20.8%
7Y CAGR
19.4%
Operating Expenses Annual Cr is falling faster than historical averages.

Beauty Health Co (Class A) balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Total Shareholders Fund Beauty Health Co (Class A) Dec-2025 Total Shareholders Fund is $61 Million which is growth of 17.9% YoY.

  • NEGATIVE

    Total Assets Beauty Health Co (Class A) Dec-2025 Total Assets is $500 Million which is growth of -27.1% YoY.

Beauty Health Company (The) - Ordinary Shares - Class A, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18
⌄
-20.9%
17.5%
499.8685.7929.11,008.91,218.8222.8226.4-
⌄
-19.4%
11.7%
438.8633.9869.7837.4916.5252.8227.6-
⌄
-29.1%
-
61.151.859.4171.5302.3-30-1.2-
Total Capitalization Ann.
-30.7%
10.1%
301.5604797.8905.61,032.2186.1179.6-
Tangible Assets Ann.
-
-
-101.3-119.2-128.60.5122.6-179.4-160-
Working Capital Ann.
-44.4%
34.3%
123.2409583.2716924.528.216.4
Invested Capital Ann.
-22.3%
17.9%
425.5604797.8905.61,032.2186.6188.6-
Tangible Book Value Ann.
-
-
-101.3-119.2-128.60.5122.6-179.4-160-
Borrowings Ann.
-20.4%
11.8%
378.8568.2752.3751.8746.4216.5189.8-
Net Debt Ann.
-7.4%
-8.7%
131.7182.1215.4166-207.1182.5-
Share Issued Ann.
-1.2%
0.3%
127.5124.9122.9132.2150.6125.4125.4-
Number Of Shares End
-2.6%
0.3%
127.5124.4128.7138.1146.8125.4--
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-27.1%
2Y CAGR
-26.7%
3Y CAGR
-20.9%
5Y CAGR
17.5%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
173.2%
2Y CAGR
27.3%
3Y CAGR
36.6%
5Y CAGR
43.2%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
18%
2Y CAGR
1.4%
3Y CAGR
-29.1%
Total ShareHolders Funds Annual growth is stable compared to historical averages.

Beauty Health Co (Class A) ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Book Value Per Share Beauty Health Co (Class A) Book Value Per Share is $1 which is growth of 7.7% YoY.

  • NEUTRAL

    ROE Beauty Health Co (Class A) ROE is 0% which is growth of 0% YoY.

Beauty Health Company (The) - Ordinary Shares - Class A, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18
RoA Ann. %
-
-
--3.60%-10.33%3.98%-52.04%-13.32%-0.72%-
ROE Ann. %
-
-
--52.34%-86.73%18.74%-275.47%---
ROIC %
-
-
--1.6-1.40.7-1.8---
OPM Ann. %
-
-
-6.92%-20.27%-32.89%-6.64%-14.09%-14.43%8.08%8.96%
Inventory Turnover Ratio Ann.
-
-
-1.92.31.52.72.43.1-
Asset Turnover Ann. %
-
-
-0.40.40.30.40.50.7-
Working Capital Turnover Ann.
68.7%
-10.6%
2.40.80.70.50.34.210.2-
Quick Ratio Ann.
-
-
-5.958.812.51.10.8-
Current Ratio Ann.
-
-
-76.110.813.11.91.4-
Interest Coverage Ratio Ann.
-
-
--1.8-6.54.4-31-0.80.81
LT Debt To Equity Ann.
-
-
-10.912.64.42.5---
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Beauty Health Co (Class A) cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Cash From Operating Activity Beauty Health Co (Class A) Dec-2025 Cash From Operating Activity is $37 Million which is growth of 132.3% YoY.

  • POSITIVE

    Net Cash Flow Beauty Health Co (Class A) Dec-2025 Net Cash Flow is $-143 Million which is growth of 4.3% YoY.

Beauty Health Company (The) - Ordinary Shares - Class A, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18
⌄
-
-
37.516.121.8-106.6-28.4-12.41.7-0.9
⌄
-
-
-5.2-6.8-31.5-18.9-37.7-3.8-12.5-8.4
⌄
-
-
-174.9-158.3-37.5-205.295918.314.611.2
Cash Plus Cash Eqv. End Of Year Ann.
-25.7%
89.6%
232.7370.1523568.2901.99.57.33.6
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-142.6-149-47.2-330.7892.923.81.8
Cash Plus Cash Eqv. Begin Of Year Ann.
-25.7%
119.3%
370.1523568.2901.99.57.33.61.8
Income Tax Paid Supplemental Data Ann.
-
-
-2.82.3-1.72.40.91.6
Interest Paid Supplemental Data Ann.
13.7%
1.3%
14.489.49.810.313.515.79.4
Capex Ann.
-
-
-5.2-6.8-13.1-17.4-15.6-3.8-10.4-7.9
Issuance Of Capital Stock Ann.
-
-
--------
Issuance Of Debt Ann.
-
45.4%
237.6-75536.528.5118.7
Repayment Of Debt Ann.
-
-
-411-156.1-230.5-16.8-12-5
Repurchase Of Capital Stock Ann.
-
-
-32.4-160-0.2
Free Cash Flow Ann.
-
-
32.39.38.7-124-44-16.3-8.7-8.8
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
132.9%
2Y CAGR
31.2%
Cash from Operating Activity Annual growth is lower than historical averages.
×